[{"NetIncomeLoss_1_Q3_USD":3618000.0,"Liabilities_0_Q3_USD":42874000.0,"Investments_0_Q3_USD":42000000.0,"IncreaseDecreaseInReceivables_3_Q3_USD":-5994000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccruedLiabilitiesCurrent_0_Q3_USD":8695000.0,"InterestPaidNet_3_Q3_USD":5000.0,"PaymentsToAcquireShortTermInvestments_3_Q3_USD":29049000.0,"InventoryFinishedGoods_0_Q3_USD":44000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":78000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":8518000.0,"Depreciation_3_Q3_USD":1600000.0,"Depreciation_1_Q3_USD":600000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":0.0,"AssetsCurrent_0_Q3_USD":125382000.0,"OperatingLeaseExpense_3_Q3_USD":4500000.0,"OperatingLeaseExpense_1_Q3_USD":1600000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":50596000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":16041000.0,"FinanceLeaseLiabilityNoncurrent_0_Q3_USD":74000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":28369000.0,"CostOfGoodsAndServicesSold_1_Q3_USD":9787000.0,"FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_0_Q3_USD":120000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":500000.0,"FinanceLeaseInterestExpense_3_Q3_USD":100000.0,"FinanceLeaseInterestExpense_1_Q3_USD":100000.0,"RevenueNotFromContractWithCustomerOther_3_Q3_USD":1238000.0,"RevenueNotFromContractWithCustomerOther_1_Q3_USD":1238000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":21487000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":43507000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_0_Q3_USD":10709000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-52000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":2913000.0,"InventoryRawMaterials_0_Q3_USD":9265000.0,"EarningsPerShareBasic_1_Q3_USD":0.08,"EarningsPerShareBasic_3_Q3_USD":-0.21,"AllowanceForDoubtfulOtherReceivablesCurrent_0_Q3_USD":4600000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":-68000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":57000.0,"AccruedBonusesCurrent_0_Q3_USD":4291000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":47314000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":45112000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":747000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-8000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-18000.0,"ForeignCurrencyTransactionGainLossRealized_3_Q3_USD":-59000.0,"AccountsReceivableNetCurrent_0_Q3_USD":26174000.0,"CommonStockValue_0_Q3_USD":502587000.0,"Revenues_1_Q3_USD":32258000.0,"Revenues_3_Q3_USD":78950000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":0.0,"IncreaseDecreaseInOtherCurrentAssets_3_Q3_USD":633000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":1649000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":1987000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_0_Q3_USD":17824000.0,"RestrictedCash_0_Q3_USD":200000.0,"OtherAssetsCurrent_0_Q3_USD":3586000.0,"IncreaseDecreaseInInventories_3_Q3_USD":3264000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-9299000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":3550000.0,"NumberOfReportableSegments_3_Q3_segment":1.0,"CommonStockSharesIssued_0_Q3_shares":45315000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":70094000.0,"Assets_0_Q3_USD":157504000.0,"CommonStockSharesOutstanding_0_Q3_shares":45315000.0,"EarningsPerShareDiluted_3_Q3_USD":-0.21,"EarningsPerShareDiluted_1_Q3_USD":0.08,"RestrictedCashNoncurrent_0_Q3_USD":211000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":78000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":163000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2675000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":6235000.0,"GainLossOnDispositionOfAssets1_3_Q3_USD":-30000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":45112000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":45272000.0,"InventoryWorkInProcess_0_Q3_USD":771000.0,"LiabilitiesCurrent_0_Q3_USD":21313000.0,"AssetImpairmentCharges_3_Q3_USD":0.0,"AccountsPayableCurrent_0_Q3_USD":6475000.0,"NonoperatingIncomeExpense_1_Q3_USD":101000.0,"InterestExpense_3_Q3_USD":5000.0,"InterestExpense_1_Q3_USD":2000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":43718000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":2182000.0,"GrossProfit_3_Q3_USD":50581000.0,"GrossProfit_1_Q3_USD":22471000.0,"ShortTermLeaseCost_3_Q3_USD":100000.0,"ShortTermLeaseCost_1_Q3_USD":100000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q3_USD":309000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":340000.0,"ProceedsFromPaymentsForOtherFinancingActivities_3_Q3_USD":-32000.0,"NetIncomeLoss_3_Q3_USD":-9356000.0,"NonoperatingIncomeExpense_3_Q3_USD":561000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":9902000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":16740000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_3_Q3_USD":39123000.0,"ShareBasedCompensation_3_Q3_USD":10819000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":24796000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0_Q3_USD":7115000.0,"CommonStockSharesAuthorized_0_Q3_shares":75000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":77712000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":31020000.0,"OperatingIncomeLoss_3_Q3_USD":-9917000.0,"OperatingIncomeLoss_1_Q3_USD":3517000.0,"InventoryNet_0_Q3_USD":10080000.0,"InvestmentIncomeInterest_3_Q3_USD":574000.0,"InvestmentIncomeInterest_1_Q3_USD":121000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":157504000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":2674000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-388035000.0,"FinanceLeaseRightOfUseAsset_0_Q3_USD":120000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3_Q3_USD":3140000.0,"OperatingExpenses_3_Q3_USD":60498000.0,"OperatingExpenses_1_Q3_USD":18954000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":74000.0,"FinanceLeaseLiabilityCurrent_0_Q3_USD":41000.0,"OtherLiabilitiesCurrent_0_Q3_USD":41000.0,"StockholdersEquity_0_Q3_USD":114630000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q3_USD":0.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1556000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":187000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":70016000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-24000.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":16000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":6102000.0,"ShortTermInvestments_0_Q3_USD":42035000.0,"Ticker":"VCEL","CIK":"887359","name":"VERICEL CORP","OfficialName":"Vericel Corporation Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1756775066.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]